DJI46,037.21-0.84%
GDAXI22,619.03-1.47%
GSPC6,516.30-1.15%
HSI24,856.43-1.89%
IXIC21,596.63-1.52%
N22553,603.65-0.27%
AAPL255.69+1.21%
AMZN210.22-0.70%
CL94.55+4.68%
EURUSD1.1535-0.26%
GBPUSD1.3337-0.23%
GC4,393.00-3.50%
GOOG283.02-2.27%
JPM291.21-1.43%
META554.55-6.78%
MSFT367.13-1.05%
NVDA173.67-2.81%
TSLA377.31-2.24%
DJI46,037.21-0.84%
GDAXI22,619.03-1.47%
GSPC6,516.30-1.15%
HSI24,856.43-1.89%
IXIC21,596.63-1.52%
N22553,603.65-0.27%
AAPL255.69+1.21%
AMZN210.22-0.70%
CL94.55+4.68%
EURUSD1.1535-0.26%
GBPUSD1.3337-0.23%
GC4,393.00-3.50%
GOOG283.02-2.27%
JPM291.21-1.43%
META554.55-6.78%
MSFT367.13-1.05%
NVDA173.67-2.81%
TSLA377.31-2.24%
DJI46,037.21-0.84%
GDAXI22,619.03-1.47%
GSPC6,516.30-1.15%
HSI24,856.43-1.89%
IXIC21,596.63-1.52%
N22553,603.65-0.27%
AAPL255.69+1.21%
AMZN210.22-0.70%
CL94.55+4.68%
EURUSD1.1535-0.26%
GBPUSD1.3337-0.23%
GC4,393.00-3.50%
GOOG283.02-2.27%
JPM291.21-1.43%
META554.55-6.78%
MSFT367.13-1.05%
NVDA173.67-2.81%
TSLA377.31-2.24%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
USA Seeking Alpha EN

ADMA Biologics extends selloff as Cantor downgrades after short report

Mar 26, 2026 &03362626202631; 14:36 UTC seekingalpha.com Trending 2/5
Read original on seekingalpha.com ↗
↘
Negative for markets
Sentiment score: -72/100
High impact Immediate effect (hours)
WHAT THIS MEANS
ADMA Biologics faces a sharp selloff following a Cantor downgrade triggered by a short report, creating immediate downward pressure. The fresh catalyst combined with analyst capitulation suggests continued weakness in the near term.
AI CONFIDENCE
72% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
↓
ADMA
ADMAStock
Expected to decline
Fresh Cantor downgrade following short report; selloff already underway but momentum likely to continue as institutional holders reassess; short-seller credibility + analyst capitulation = capitulation cascade risk
⇅
S&P 500
^GSPCIndex
High volatility expected
Broader market weakness (-0.44%) and elevated VIX (26.22) suggest risk-off sentiment; biotech/small-cap names under pressure but S&P 500 resilience indicates selective selling
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
ADMA is in acute downside momentum; short-term traders should wait for stabilization or support test before entry. Risk/reward favors waiting for capitulation signal (volume spike, reversal candle) rather than chasing the decline. Avoid catching falling knife in first 30min. [MOVE:-8.5%]
KEY SIGNALS
Fresh downgrade from major analyst (Cantor)Short report catalyst triggering institutional reviewElevated VIX and broad market weakness supporting downsideMomentum selling likely to accelerate in first 1-2 hours
SECTORS INVOLVED
HealthcareBiotechnology
Analysis generated on Mar 26, 2026 at 14:40 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

ADMA Biologics drops amid short report from Culper Research
Seeking Alpha Mar 24, 18:44 Negative
Brown-Forman jumps on report Pernod Ricard weighing purchase
Seeking Alpha Mar 26, 16:27 Positive
United Parks & Resorts sued by the DOJ over wheeled walker ban
Seeking Alpha Mar 26, 16:20 Negative
Analyshusets dystra H&M-dom: ”Besvikelse – sälj”
Dagens Industri Mar 26, 16:11 Negative
Inventronics GAAP EPS of -$3.10c, revenue of $1.55M
Seeking Alpha Mar 26, 16:10 Negative